NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The NBA is in the midst of a high-stakes investigation of the Clippers over allegations of violating the salary cap. Here is what it could mean to the team and its owner Steve Ballmer.Read More
NBA Panic Meter Power Rankings: Which teams should be most concerned about the first roundApril 27, 2026